Unknown

Dataset Information

0

Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery.

ABSTRACT: In order to identify novel lead structures for human toll-like receptor 4 (hTLR4) modulation virtual high throughput screening by a peta-flops-scale supercomputer has been performed. Based on the in silico studies, a series of 12 compounds related to tryptamine was rationally designed to retain suitable molecular geometry for interaction with the hTLR4 binding site as well as to satisfy general principles of drug-likeness. The proposed compounds were synthesized, and tested by in vitro and ex vivo experiments, which revealed that several of them are capable to stimulate hTLR4 in vitro up to 25% activity of Monophosphoryl lipid A. The specific affinity of the in vitro most potent substance was confirmed by surface plasmon resonance direct-binding experiments. Moreover, two compounds from the series show also significant ability to elicit production of interleukin 6.

SUBMITTER: Honegr J 

PROVIDER: S-EPMC6017214 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery.

Honegr Jan J   Dolezal Rafael R   Malinak David D   Benkova Marketa M   Soukup Ondrej O   Almeida Joyce S F D de JSFD   Franca Tanos C C TCC   Kuca Kamil K   Prymula Roman R  

Molecules (Basel, Switzerland) 20180104 1

In order to identify novel lead structures for human toll-like receptor 4 (<i>h</i>TLR4) modulation virtual high throughput screening by a peta-flops-scale supercomputer has been performed. Based on the in silico studies, a series of 12 compounds related to tryptamine was rationally designed to retain suitable molecular geometry for interaction with the <i>h</i>TLR4 binding site as well as to satisfy general principles of drug-likeness. The proposed compounds were synthesized, and tested by in v  ...[more]

Similar Datasets

Unknown Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists.
| S-EPMC4882283 | biostudies-other
Unknown Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists.
| S-EPMC6209530 | biostudies-literature
Unknown A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation.
| S-EPMC5063506 | biostudies-literature
Unknown Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists.
| S-EPMC4346271 | biostudies-literature
Unknown A combined ligand- and structure-based virtual screening protocol identifies submicromolar PPAR? partial agonists.
| S-EPMC3517154 | biostudies-literature
Unknown Ligand-based pharmacophore modeling, virtual screening and biological evaluation to identify novel TGR5 agonists.
| S-EPMC8695346 | biostudies-literature
Unknown Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant.
| S-EPMC8602664 | biostudies-literature
Unknown Virtual Screening of Human Class-A GPCRs Using Ligand Profiles Built on Multiple Ligand-Receptor Interactions.
| S-EPMC7415681 | biostudies-literature
Unknown Structure-based rational design of a Toll-like receptor 4 (TLR4) decoy receptor with high binding affinity for a target protein.
| S-EPMC3281905 | biostudies-literature
Unknown Biological characterization of a novel class of toll-like receptor 7 agonists designed to have reduced systemic activity.
| S-EPMC3417490 | biostudies-literature